These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 5844429

  • 1. Iron chelation in acute iron poisoning and chronic hypersiderosis.
    Walsh JR, Gillick JB.
    Clin Pediatr (Phila); 1965 Nov; 4(11):633-8. PubMed ID: 5844429
    [No Abstract] [Full Text] [Related]

  • 2. [The use of desferrioxamine in iron poisoning and hemosiderosis].
    Karlsson B, Lagercrantz R, Brann I, Strandberg O, Reizenstein P.
    Nord Med; 1965 Oct 07; 74(40):985-8. PubMed ID: 5836665
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative evaluation of two models of hemosiderosis for analysis of iron chelators].
    Minina LT, Prostakova TM, Meshchano AIu, Kol'tsova GN, Bovenko VN.
    Biull Eksp Biol Med; 1996 Sep 07; 122(9):359-60. PubMed ID: 8974501
    [No Abstract] [Full Text] [Related]

  • 5. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
    Vichinsky E, Pakbaz Z, Onyekwere O, Porter J, Swerdlow P, Coates T, Lane P, Files B, Mueller BU, Coïc L, Forni GL, Fischer R, Marks P, Rofail D, Abetz L, Baladi JF.
    Acta Haematol; 2008 Sep 07; 119(3):133-41. PubMed ID: 18408362
    [Abstract] [Full Text] [Related]

  • 6. Advances in the use of iron-chelating agents for the treatment of iron overload.
    Modell B.
    Prog Hematol; 1979 Sep 07; 11():267-312. PubMed ID: 392593
    [No Abstract] [Full Text] [Related]

  • 7. Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.
    Shashaty G, Frankewich R, Chakraborti T, Choudary J, Al-Fayoumi S, Kacuba A, Castillo S, Robie-Suh K, Rieves D, Weiss K, Pazdur R.
    Oncology (Williston Park); 2006 Dec 07; 20(14):1799-1806, 1811; discussion 1811-13, 1817. PubMed ID: 17263129
    [Abstract] [Full Text] [Related]

  • 8. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH.
    Curr Top Hematol; 1978 Dec 07; 1():127-50. PubMed ID: 400529
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron chelating therapy in thalassemia: current problems.
    Russo G.
    Haematologica; 1990 Dec 07; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract] [Full Text] [Related]

  • 12. Transfusion haemosiderosis and chelation therapy.
    Ley TJ, Griffith P, Nienhuis AW.
    Clin Haematol; 1982 Jun 07; 11(2):437-64. PubMed ID: 7042160
    [No Abstract] [Full Text] [Related]

  • 13. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
    Maspes V, Tamigaki M, Gomes ZJ, Jamra M.
    Rev Hosp Clin Fac Med Sao Paulo; 1966 Jun 07; 21(4):181-95. PubMed ID: 5918167
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent developments in iron chelation therapy.
    Cario H, Janka-Schaub G, Janssen G, Jarisch A, Strauss G, Kohne E.
    Klin Padiatr; 2007 Jun 07; 219(3):158-65. PubMed ID: 17525910
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
    Schafer AI, Rabinowe S, Le Boff MS, Bridges K, Cheron RG, Dluhy R.
    Arch Intern Med; 1985 Jul 07; 145(7):1217-21. PubMed ID: 3925909
    [Abstract] [Full Text] [Related]

  • 17. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A, Raybaud C, Bernard PJ, Aquaron R, Passeron P.
    Mars Med; 1967 Jul 07; 104(4):331-7. PubMed ID: 5621537
    [No Abstract] [Full Text] [Related]

  • 18. Desferal therapy in iron storage disease.
    Thompson RB, Owen DM, Bell WN.
    Am J Med Sci; 1967 Apr 07; 253(4):453-60. PubMed ID: 6021380
    [No Abstract] [Full Text] [Related]

  • 19. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
    Fainshtein FE, Trubina NS, Sobaleva IuG, Rozanova NS, Voronina AN.
    Probl Gematol Pereliv Krovi; 1968 Aug 07; 13(8):31-8. PubMed ID: 5736846
    [No Abstract] [Full Text] [Related]

  • 20. [Use of chelates for removal of excess iron from the body].
    Meshchanov AIu, Romanova MZh, Kol'tsova GN, Shcherbinina SP.
    Gematol Transfuziol; 1989 Mar 07; 34(3):40-5. PubMed ID: 2656376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.